Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov-Dec;7(8):2812-2820.e3.
doi: 10.1016/j.jaip.2019.05.009. Epub 2019 May 22.

Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis

Whitney W Stevens  1 , Anju T Peters  1 , Bruce K Tan  2 , Aiko I Klingler  1 , Julie A Poposki  1 , Kathryn E Hulse  1 , Leslie C Grammer  1 , Kevin C Welch  2 , Stephanie S Smith  2 , David B Conley  2 , Robert C Kern  3 , Robert P Schleimer  3 , Atsushi Kato  4
Affiliations

Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis

Whitney W Stevens et al. J Allergy Clin Immunol Pract. 2019 Nov-Dec.

Abstract

Background: Chronic rhinosinusitis (CRS) is a heterogeneous disease characterized by mucosal inflammation in the nose and paranasal sinuses. Inflammation in CRS is also heterogeneous and is mainly characterized by type 2 (T2) inflammation, but subsets of patients show type 1 (T1) and type 3 (T3) inflammation. Whether inflammatory endotypes are associated with clinical phenotypes has yet to be explored in detail.

Objective: To identify associations between inflammatory endotypes and clinical presentations in CRS.

Methods: We compared 121 patients with nonpolypoid CRS (CRSsNP) and 134 patients with polypoid CRS (CRSwNP) and identified inflammatory endotypes using markers including IFN-γ (T1), eosinophil cationic protein (T2), Charcot-Leyden crystal galectin (T2), and IL-17A (T3). We collected clinical parameters from medical and surgical records and examined whether there were any associations between endotype and clinical features.

Results: The presence of nasal polyps, asthma comorbidity, smell loss, and allergic mucin was significantly associated with the presence of T2 endotype in all patients with CRS. The T1 endotype was significantly more common in females, and the presence of pus was significantly associated with T3 endotype in all patients with CRS. We further analyzed these associations in CRSsNP and CRSwNP separately and found that smell loss was still associated with T2 endotype and pus with the T3 endotype in both CRSsNP and CRSwNP. Importantly, patients with CRS with T2 and T3 mixed endotype tended to have clinical presentations shared by both T2 and T3 endotypes.

Conclusions: Clinical presentations are directly associated with inflammatory endotypes in CRS. Identification of inflammatory endotypes may allow for more precise and personalized medical treatments in CRS.

Keywords: Chronic rhinosinusitis; Clinical presentation; Endotype-phenotype association; Inflammatory endotype.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no conflict of interest as to the interpretation and presentation of this manuscript.

Figures

Figure 1.
Figure 1.
Patterns of inflammatory endotypes in CRS.
Figure 2.
Figure 2.. Odds ratio for clinical presentations within endotypes in all CRS.
Multivariate logistic regression analysis with predictor endotype controlling for age, sex, asthma, atopy and NP and the corresponding odds ratio (OR), 95% confidence interval (CI) and p-value for headache/migraine (n=230), smell loss (n=230) and intra-operative pus (n=217) in CRS. * p<0.05, ** p<0.01 by logistic regression analysis.
Figure 3.
Figure 3.. Endotype-phenotype associations in CRSsNP and CRSwNP.
Association of clinical presentations with the absence and/or presence of all T1, T2 or T3 endotypes in CRSsNP (A) and CRSwNP (B). * p<0.05, ** p<0.01 by the Chi-square test.
Figure 4.
Figure 4.. Endotype-phenotype association in single, mixed and untypeable endotypes of CRSsNP and CRSwNP.
Comparison of clinical presentations between untypeable, single or mixed endotypes in CRSsNP (A) and CRSwNP (B). * p<0.05, ** p<0.01 by the Chi-square test.
See this image and copyright information in PMC

Comment in

References

    1. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl 2012; 23:3 p preceding table of contents, 1–298. - PubMed
    1. Orlandi RR, Kingdom TT, Hwang PH, Smith TL, Alt JA, Baroody FM, et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol 2016; 6 Suppl 1:S22–209. - PubMed
    1. Smith KA, Orlandi RR, Rudmik L. Cost of adult chronic rhinosinusitis: A systematic review. Laryngoscope 2015; 125:1547–56. - PubMed
    1. Rudmik L Economics of Chronic Rhinosinusitis. Curr Allergy Asthma Rep 2017; 17:20. - PubMed
    1. Kato A Immunopathology of chronic rhinosinusitis. Allergol Int 2015; 64:121–30. - PMC - PubMed

Publication types

MeSH terms